The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Featured Story
If you’re living with HIV and wondering how the new coronavirus may affect you, here are some tips to help you look after yourself.
Despite intensified efforts to increase HIV testing in sub-Saharan Africa, poorer and less educated people are still missing out.
Long-acting, injectable cabotegravir is as effective as daily PrEP pills at preventing HIV among cisgender men and transgender women who have sex with men.
When starting treatment in the third trimester, women taking dolutegravir more likely to achieve undetectable viral loads at the time of giving birth compared with those taking efavirenz.
Study finds a programme in Côte d’Ivoire offering male-only groups and peer support is helping men test for HIV, accept treatment and stay on it.
HIV drug resistance among treatment-naïve people in China rising rapidly from 2012 and tops 10% in Central China.
Expanding access to even the most basic form of cervical cancer screening and treatment could prevent thousands of deaths among women living with HIV in Kenya
A pilot scheme that immediately rebooks and provides a reminder for an HIV retest six months later increases attendance by 25%.
People on integrase inhibitors found to gain more weight on average than those on other treatment regimens
In all regions, children show significant immune recovery after switching to second-line treatment, but still too many children switch late.
Rapid HIV testing at six weeks more than doubles the proportion of HIV-positive newborns getting a confirmatory diagnosis.
